Michael Hencke

Michael Hencke is an experienced professional in investor relations and business development, currently serving as Managing Director at Kendall Investor Relations, LLC. Previously, Michael held several key positions at Biogen, including Executive Director, Sr. Director, and Director of Investor Relations, demonstrating a strong background in the field. Prior to that, Michael co-founded Semprus BioSciences, contributing as a Business Development and Marketing Manager while also working as a Consultant. Additionally, Michael gained early experience as a Summer Intern in Global Neurology Marketing at Biogen and as an Analyst at Health Advances.